Recent advances in the molecular genetics of cancer

Annals of Oncology

Volumn 9, Issue 1, 1998, Pages 23-29

  Spataro, V ^a,b  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b Ospedale Civico Lugano   (Switzerland)

Author keywords

Apoptosis; Cancer; Molecular genetics; Multistep progression

Indexed keywords

PROTEIN P53; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CANCER GENETICS; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CELL CYCLE; GENE LOCUS; GENOME; HETEROZYGOSITY LOSS; HUMAN; MOLECULAR GENETICS; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

ANIMALS; CELL CYCLE; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; MICE; MICE, TRANSGENIC; MULTIGENE FAMILY; NEOPLASMS; NEOPLASMS, EXPERIMENTAL;

EID: 0031928943     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008263531395     Document Type: Review

References (36)

1. Gnarra JR, Duan DR, Weng Y et al. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1996; 1242: 201-10.
2. Pause A, Aso T, Linehan WM et al. Interaction of von Hippel-Lindau tumor suppressor gene product with elongin. Methods Enzymol 1996; 274: 436-41.
3. Pause A, Lee S, Worrell RA et al. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 1997; 94: 2156-61.
4. Kipreos ET, Lander LE, Wing JP et al. cul-1 is required for cell cycle exit in C. elegans and identifies a novel gene family. Cell 1996; 85: 829-39.
5. Pagano M, Tam SW, Theodoras AM et al. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269: 682-5.
6. Gnarra JR, Zhou S, Merrill MJ et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 1996; 93: 10589-94.
7. Spataro V, Norbury C, Harris A. The ubiquitin/proteasome pathway in cancer. Br J Cancer, in press.
8. Riggins GJ, Kinzler KW, Vogelstein B et al. Frequency of Smad gene mutations in human cancers. Cancer Res 1997; 57: 2578-80.
9. Lagna G, Hata A, Hemmati-Brivanlou A et al. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 1996; 383: 832-6.
10. Shi Y, Hata A, Lo R, Massague J et al. A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 1997; 388: 87-93.
11. Haldar S, Chintapalli J, Croce CM. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 1996; 56: 1253-5.
12. Huebner K, Hadaczek P, Siprashvili Z et al. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FRA3B. Biochim Biophys Acta 1997; 1332: M65-M70.
13. Sozzi G, Sard L, De Gregorio L et al. Association between cigarette smoking and FHIT gene alterations in lung cancer. Cancer Res 1997; 57: 2121-3.
14. Li J, Clifford Y, Liaw D et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science 1997; 275: 1943-7.
15. Liaw D, Marsh DJ, Dahia PL et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet 1997; 16: 64-7.
16. Nishitani H, Nurse P. p65cdc18 plays a major role controlling the initiation of DNA replication in fission yeast. Cell 1995; 83: 397-405.
17. Palmero I, McConnell B, Parry D et al. Accumulation of p/6INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene 1997; 15: 495-503.
18. Diehl JA, Zindy F, Sherr CJ. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway. Genes Dev 1997; 11: 957-72.
19. Catzavelos C, Bhattacharya N, Ung YC et al. Decreased levels of the cell-cycle inhibitor p27/Kipl protein: Prognostic implications in primary breast cancer. Nature Med 1997; 3: 227-30.
20. Fredersdorf S, Burns J. Milne AM et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997; 94: 6380-5.
21. Loda M, Cukor B, Tam SW et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997; 3: 231-4.
22. Porter PL, Malone KE, Heagerty PJ et al. Expression of cell-cycle regulators p27/Kipl and cyclin E, alone or in combination, correlate with survival in young breast cancer patients. Nature Med 1997; 3: 222-5.
23. Vlach J, Hennecke S, Alevizopoulos K et al. Growth arrest by the cyclin-dependent kinase inhibitor p27/Kipl is abrogated by c-myc. EMBO J 1996; 15: 6595-604.
24. Field SJ, Tsai FY, Kuo A et al. E2F1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-61.
25. Yamasaki L, Jacks T, Bronson R et al. Tumor induction and tissue atrophy in mice lacking E2F1. Cell 1996; 85: 537-48.
26. Hsieh JK, Fredersdorf S, Kouzarides T et al. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev 1997; 11: 1840-52.
27. Saenz Robles MT, Symonds H, Chen J et al. Induction versus progression of brain tumour development: Differential functions for the pRb- and p53-targeting domains of SV40 T antigen. Mol Cell Biol 1994; 14: 2686-98.
28. Symonds H, Krall L, Remington L et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994; 78: 703-11.
29. Knudson CM, Tung KSK, Tourtelotte WG et al. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96-9.
30. Haupt Y, Maya R, Kazaz A et al. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296-9.
31. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387: 299-303.
32. Allen JD, Verhoeven E, Domen J et al. Pim-2 transgene induces lymphoid tumours, exhibiting potent synergy with c-myc. Oncogene 1997; 15: 1133-41.
33. Alkema MJ, Bronk M,Verhoeven E et al. Identification of Bmi-1-interacting proteins as constituents of a multimeric mammalian polycomb complex. Genes Dev 1997; 11: 226-40.
34. Liao SY, Stanbridge EJ. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Cancer Epidemiol Biomarkers Prev 1996; 5: 549-57.
35. Liao SY, Aurelio ON, Jan K et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 1997; 57: 2827-31.
36. Larson AA, Kern S, Curtiss S et al. High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res 1997; 57: 4082-90.